摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-β-D-ribofuranosyl-1H-imidazo<4,5-c>pyridine | 6703-46-4

中文名称
——
中文别名
——
英文名称
1-β-D-ribofuranosyl-1H-imidazo<4,5-c>pyridine
英文别名
1-β-D-Ribofuranosylimidazo<4,5-c>pyridin;1-<β-D-Ribofuranosyl>-1H-imidazo<4,5-c>pyridin;1-β-D-Ribofuranosyl-1H-imidazo<4.5-c>pyridin;1-imidazo[4,5-c]pyridin-1-yl-β-D-1-deoxy-ribofuranose;(2R,3S,4R,5R)-2-(hydroxymethyl)-5-imidazo[4,5-c]pyridin-1-yloxolane-3,4-diol
1-β-D-ribofuranosyl-1H-imidazo<4,5-c>pyridine化学式
CAS
6703-46-4
化学式
C11H13N3O4
mdl
——
分子量
251.242
InChiKey
PJSNMDJSTZLBGP-GWOFURMSSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    594.9±60.0 °C(Predicted)
  • 密度:
    1.75±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    -1.2
  • 重原子数:
    18
  • 可旋转键数:
    2
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.45
  • 拓扑面积:
    101
  • 氢给体数:
    3
  • 氢受体数:
    6

SDS

SDS:1b46fea6497879a5fa5a33b5a4b8c1d0
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    1-β-D-ribofuranosyl-1H-imidazo<4,5-c>pyridine磷酸三乙酯三氯氧磷 作用下, 以25%的产率得到5-azabenzimidazole
    参考文献:
    名称:
    Nicotinamide Benzimidazolide Dinucleotides, Non-Cyclisable Analogues of NAD+
    摘要:
    Benzimidazole-based nucleotides and dinucleotides have been synthesised to increase the range of chemical tools available to probe the NAD(+) biology space. They were examined for their reactivity in alkylation-type reactions, where they yielded unstable alkylated heteoaromatic adducts, both chemically and enzymatically. While unsuited for NAD(+) cyclases, these NAD(+) analogues could be viable substrates for non-adenine modifying NAD(+)-dependent enzyme classes.
    DOI:
    10.1055/s-0034-1379000
  • 作为产物:
    描述:
    4-Chlor-1-β-D-ribofuranosyl-1H-imidazo<4,5-c>pyridin 在 palladium on activated charcoal 氢气 作用下, 以 乙醇 为溶剂, 以23%的产率得到1-β-D-ribofuranosyl-1H-imidazo<4,5-c>pyridine
    参考文献:
    名称:
    咪唑并[4,5-c]吡啶(3-脱氮嘌呤)及其核苷可作为免疫抑制剂和抗炎药。
    摘要:
    合成了多种咪唑并[4,5-c]吡啶(3-脱氮嘌呤)。使用这些糖苷配基作为戊糖基受体,通过涉及从适当的嘧啶核苷转移戊糖基部分的酶促方法制备相应的核糖核苷和2'-脱氧核糖核苷。对于大多数咪唑并[4,5-c]吡啶,从酶催化反应中获得的产物仅在1-位戊糖基化。然而,在4-位具有H或N 3的糖苷配基发生了一些3-戊糖基化。除了4-氨基-1H-咪唑并[4,5-c]吡啶核糖核苷的2'-脱氧同源物外,还合成了5'-脱氧和2',5'-二脱氧同源物。测试了所有糖苷配基及其核苷对培养物中哺乳动物细胞的毒性。没有一个具有明显的细胞毒性。还评估了这些化合物在体外抑制淋巴细胞介导的细胞溶解的能力。3-Deazaadenosine(23)及其2'-deoxy同系物(38)是最有效的抑制剂(ED50 = 20 microM)。除了这两个体外测试,还确定了大鼠角叉菜胸膜炎模型中炎症反应的体内抑制作用。在该体内测试中,3-脱
    DOI:
    10.1021/jm00151a022
点击查看最新优质反应信息

文献信息

  • Imidazo[4,5-c]pyridines (3-deazapurines) and their nucleosides as immunosuppressive and antiinflammatory agents
    作者:Thomas A. Krenitsky、Janet L. Rideout、Esther Y. Chao、George W. Koszalka、Fred Gurney、Ronald C. Crouch、Naomi K. Cohn、Gerald Wolberg、Ralph Vinegar
    DOI:10.1021/jm00151a022
    日期:1986.1
    A variety of imidazo[4,5-c]pyridines (3-deazapurines) were synthesized. With use of these aglycons as pentosyl acceptors, the corresponding ribonucleosides and 2'-deoxyribonucleosides were prepared by an enzymatic method involving transfer of the pentosyl moiety from appropriate pyrimidine nucleosides. With most of the imidazo[4,5-c]pyridines, the products obtained from the enzyme-catalyzed reactions
    合成了多种咪唑并[4,5-c]吡啶(3-脱氮嘌呤)。使用这些糖苷配基作为戊糖基受体,通过涉及从适当的嘧啶核苷转移戊糖基部分的酶促方法制备相应的核糖核苷和2'-脱氧核糖核苷。对于大多数咪唑并[4,5-c]吡啶,从酶催化反应中获得的产物仅在1-位戊糖基化。然而,在4-位具有H或N 3的糖苷配基发生了一些3-戊糖基化。除了4-氨基-1H-咪唑并[4,5-c]吡啶核糖核苷的2'-脱氧同源物外,还合成了5'-脱氧和2',5'-二脱氧同源物。测试了所有糖苷配基及其核苷对培养物中哺乳动物细胞的毒性。没有一个具有明显的细胞毒性。还评估了这些化合物在体外抑制淋巴细胞介导的细胞溶解的能力。3-Deazaadenosine(23)及其2'-deoxy同系物(38)是最有效的抑制剂(ED50 = 20 microM)。除了这两个体外测试,还确定了大鼠角叉菜胸膜炎模型中炎症反应的体内抑制作用。在该体内测试中,3-脱
  • Nicotinamide Benzimidazolide Dinucleotides, Non-Cyclisable Analogues of NAD+
    作者:Marie Migaud、Philip Redpath、Jolanta Haluszczak、Simon Macdonald
    DOI:10.1055/s-0034-1379000
    日期:——
    Benzimidazole-based nucleotides and dinucleotides have been synthesised to increase the range of chemical tools available to probe the NAD(+) biology space. They were examined for their reactivity in alkylation-type reactions, where they yielded unstable alkylated heteoaromatic adducts, both chemically and enzymatically. While unsuited for NAD(+) cyclases, these NAD(+) analogues could be viable substrates for non-adenine modifying NAD(+)-dependent enzyme classes.
查看更多

同类化合物

4-氨基-1-(2’,3’,5’-三-O-叔-丁基二甲基硅烷基-beta-D-呋喃核糖基)-咪唑并[4,5-a]吡啶 3-脱氮腺苷 3-去氮杂鸟苷酸 3-去氮杂鸟苷三磷酸酯 3-去氮杂鸟苷 1-(2-脱氧-beta-D-赤式-呋喃戊糖基)-1H-咪唑并[4,5-c]吡啶-4-胺 1-(2,3,5-三-O-乙酰基-beta-D-呋喃核糖基)-4,6-二氯咪唑并[4,5-c]吡啶 5'-O-(N-L-seryl)sulfamoyl-3-deaza-adenosine 5'-O-(N-glycyl)sulfamoyl-3-deaza-adenosine 5'-O-(N-L-isoleucyl)sulfamoyl-3-deaza-adenosine 2-Fluoro-3-deaza-adenosine 4-(pyridin-3-yl)-1-(β-D-ribofuranosyl)-1H-imidazo[4,5-c]pyridine 4-(pyrrol-3-yl)-1-(β-D-ribofuranosyl)-1H-imidazo[4,5-c]pyridine 4-(pyrrol-2-yl)-1-(β-D-ribofuranosyl)-1H-imidazo[4,5-c]pyridine 4-(furan-2-yl)-1-(β-D-ribofuranosyl)-1H-imidazo[4,5-c]pyridine 1-(β-D-ribofuranosyl)-4-(thiophen-3-yl)-1H-imidazo[4,5-c]pyridine 4-cyclopropyl-1-(β-D-ribofuranosyl)-1H-imidazo[4,5-c]pyridine 4-methyl-1-(β-D-ribofuranosyl)-1H-imidazo[4,5-c]pyridine 1-(β-D-ribofuranosyl)-4-(thiophen-2-yl)-1H-imidazo[4,5-c]pyridine Adenosine, 3-deaza- (2R,3S,5R)-5-(4-Dimethylamino-imidazo[4,5-c]pyridin-1-yl)-2-hydroxymethyl-tetrahydro-furan-3-ol (2R,3S,5R)-2-Hydroxymethyl-5-(4-mercapto-imidazo[4,5-c]pyridin-1-yl)-tetrahydro-furan-3-ol 4-chloro-7-fluoro-1-(2'-C-methyl-β-D-ribofuranosyl)-imidazo[4,5-c]pyridine 4-ethyl-1-(β-D-ribofuranosyl)-1H-imidazo[4,5-c]pyridine (2R,3S,5R)-5-(4-Benzylamino-imidazo[4,5-c]pyridin-1-yl)-2-hydroxymethyl-tetrahydro-furan-3-ol 4-(Methylsulfanyl)-1-pentofuranosyl-1H-imidazo[4,5-c]pyridine 4,7-difluoro-1-(2,3,5-tri-O-benzoyl-2-C-methyl-β-D-ribofuranosyl)-imidazo[4,5-c]pyridine 6-Chloro-n,n-dimethyl-1-pentofuranosyl-1h-imidazo[4,5-c]pyridin-4-amine 2-(6-Chloro-4-methoxyimidazo[4,5-c]pyridin-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol 2-(4-Benzylsulfanyl-6-chloroimidazo[4,5-c]pyridin-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol 2-(6-Chloro-4-methylsulfanylimidazo[4,5-c]pyridin-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol N-[4-bromo-1-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]imidazo[4,5-c]pyridin-6-yl]acetamide 5,6-Diamino-1-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]imidazo[4,5-c]pyridin-4-one 1-amino-3-deazaguanosine 3-deazainosine 6-chloro-4-(cyclohexylamino)-1-(3-deoxy-β-D-ribofuranosyl)-1H-imidazo<4,5-c>pyridine [(2R,3R,4R,5R)-3,4-dibenzoyloxy-5-(4,6-dichloroimidazo[4,5-c]pyridin-1-yl)-4-methyloxolan-2-yl]methyl benzoate 4-amino-6-chloro-1-(3-deoxy-β-D-ribofuranosyl)-1H-imidazo<4,5-c>pyridine 4-amino-1-(2-deoxy-b-d-ribofuranosyl)-7-(1-naphthylethynyl)-imidazo[4,5-c]pyridine 3-Deazaguanosine 3',5'-cyclic phosphate 4-chloro-7-fluoro-1-(β-D-ribofuranosyl)imidazo[4,5-c]pyridine (2R,3S,5R)-5-(4-Benzylsulfanyl-imidazo[4,5-c]pyridin-1-yl)-2-hydroxymethyl-tetrahydro-furan-3-ol 4-(1H-pyrazol-5-yl)-1-(β-D-ribofuranosyl)-1H-imidazo[4,5-c]pyridine 2-bromo-5-methyl-1-(2,3,5-tri-O-t-butyldimethyl-silyl-β-D-ribofuranosyl)imidazo[4,5-c]pyridin-4(5H)-one 4-amino-6-fluoro-1-(2,3,5-tri-O-benzyl-β-D-arabinofuranosyl)imidazo[4,5-c]pyridine 4-amino-6-fluoro-1-(2,3,5-tri-O-benzyl-α-D-arabinofuranosyl)imidazo[4,5-c]pyridine 4-chloro-1-(2',3'-dideoxy-α-D-glycero-pentofuranosyl)-1H-imidazo<4,5-c>pyridine 4-chloro-1-(2',3'-dideoxy-5'-O-<(1'',1 ''-dimethylethyl)dimethylsilyl>-β-D-glycero-pentofuranosyl)-1H-imidazo<4,5-c>pyridine 4-chloro-1-(2',3'-dideoxy-5'-O-<(1'',1 ''-dimethylethyl)dimethylsilyl>-α-D-glycero-pentofuranosyl)-1H-imidazo<4,5-c>pyridine 4-(furan-3-yl)-1-(β-D-ribofuranosyl)-1H-imidazo[4,5-c]pyridine